Literature DB >> 33622285

Low circulating arachidonic acid is associated with macroalbuminuria in diabetic patients: a cross-sectional examination of the KAMOGAWA-DM cohort study.

Takuro Okamura1, Hanako Nakajima1, Yoshitaka Hashimoto2, Saori Majima1, Takafumi Senmaru1, Emi Ushigome1, Naoko Nakanishi1, Masahide Hamaguchi1, Mai Asano1, Masahiro Yamazaki1, Hiroshi Takakuwa3, Michiaki Fukui1.   

Abstract

BACKGROUND: Diabetic nephropathy, a major complication of diabetes, is the primary risk factor for dialysis, cardiovascular diseases, and mortality. Dietary fatty acids (FAs) have been revealed to be related with cardiovascular diseases in the general populations. The aim of this study was to investigate the association of circulating FAs with diabetic nephropathy.
METHODS: In this cross-sectional study, 190 Japanese patients with type 2 diabetes were included. Circulating FAs were measured by gas chromatography-mass spectrometry. Spearman rank correlation coefficients were used to investigate the association between the logarithm of FAs and the logarithm of urinary albumin excretion (UAE). We have performed logistic regression analysis to determine the effect of FAs on the presence of macroalbuminuria, defined as UAE value ≥300 mg/g creatinine.
RESULTS: Mean age, body mass index, and duration of diabetes were 62.7 ± 12.1 years, 25.0 ± 4.5 kg/m2, and 9.8 ± 8.7 years, respectively. In total, 26 patients were diagnosed with macroalbuminuria. The logarithm of circulating arachidonic acid (AA) was negatively associated with the logarithm of UAE (r = - 0.221, p = 0.002). Additionally, circulating AA in patients with macroalbuminuria was lower than that in patients without macroalbuminuria (112.3 ± 75.3 mg/day vs. 164.8 ± 66.0 mg/day, p <  0.001). The logarithm of circulating AA was associated with the presence of macroalbuminuria after adjusting for covariates (odds ratio of Δ1 incremental: 0.32, 95% confidence interval: 0.10-0.99, p = 0.042).
CONCLUSIONS: Circulating AA was negatively associated with UAE and the presence of macroalbuminuria.

Entities:  

Keywords:  Arachidonic acid; Cohort study; Diabetic nephropathy; Epidemiology; Fatty acids

Mesh:

Substances:

Year:  2021        PMID: 33622285      PMCID: PMC7903748          DOI: 10.1186/s12882-021-02271-8

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  37 in total

1.  Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention.

Authors:  William S Harris; Dariush Mozaffarian; Eric Rimm; Penny Kris-Etherton; Lawrence L Rudel; Lawrence J Appel; Marguerite M Engler; Mary B Engler; Frank Sacks
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

2.  Saturated fatty acid stimulates production of extracellular vesicles by renal tubular epithelial cells.

Authors:  Alyssa Cobbs; Xiaoming Chen; Yuanyuan Zhang; Jasmine George; Ming-Bo Huang; Vincent Bond; Winston Thompson; Xueying Zhao
Journal:  Mol Cell Biochem       Date:  2019-04-16       Impact factor: 3.396

3.  Long-term follow-up after tight control of blood pressure in type 2 diabetes.

Authors:  Rury R Holman; Sanjoy K Paul; M Angelyn Bethel; H Andrew W Neil; David R Matthews
Journal:  N Engl J Med       Date:  2008-09-10       Impact factor: 91.245

4.  20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.

Authors:  Tsuyoshi Ohkura; Hideki Shiochi; Youhei Fujioka; Keisuke Sumi; Naoya Yamamoto; Kazuhiko Matsuzawa; Shoichiro Izawa; Hiroshi Kinoshita; Hiroko Ohkura; Masahiko Kato; Shin-ichi Taniguchi; Kazuhiro Yamamoto
Journal:  Cardiovasc Diabetol       Date:  2013-01-22       Impact factor: 9.951

5.  Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.

Authors:  Xiaosong Gu; Jiang Xu; Liping Zhu; Timothy Bryson; Xiao-Ping Yang; Edward Peterson; Pamela Harding
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

6.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Authors:  Mitsuhiro Yokoyama; Hideki Origasa; Masunori Matsuzaki; Yuji Matsuzawa; Yasushi Saito; Yuichi Ishikawa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Hiroshige Itakura; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato
Journal:  Lancet       Date:  2007-03-31       Impact factor: 79.321

7.  Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.

Authors:  Allan Flyvbjerg; Frederik Dagnaes-Hansen; An S De Vriese; Bieke F Schrijvers; Ronald G Tilton; Ruth Rasch
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

8.  Arachidonic acid potentiates hypoxia-induced VEGF expression in mouse embryonic stem cells: involvement of Notch, Wnt, and HIF-1alpha.

Authors:  Sang Hun Lee; Min Hee Kim; Ho Jae Han
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-01       Impact factor: 4.249

9.  Fatty acids promote fatty liver disease via the dysregulation of 3-mercaptopyruvate sulfurtransferase/hydrogen sulfide pathway.

Authors:  Meng Li; Chengfu Xu; Junping Shi; Jiexia Ding; Xingyong Wan; Dahua Chen; Jianguo Gao; Chunxiao Li; Jie Zhang; Yiming Lin; Zhenhua Tu; Xiaoni Kong; Youming Li; Chaohui Yu
Journal:  Gut       Date:  2017-09-06       Impact factor: 23.059

Review 10.  Prostaglandins in the pathogenesis of kidney diseases.

Authors:  Yuanyuan Li; Weiwei Xia; Fei Zhao; Zhaoying Wen; Aihua Zhang; Songming Huang; Zhanjun Jia; Yue Zhang
Journal:  Oncotarget       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.